fda glp-1 warning news september 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA Issues 30 Warning Letters

Post-marketing surveillance and observational studies have yielded mixed results, though the absolute risk appears very low given the rarity of MTC

Mod GRF 1-29 helps accelerate the healing process of muscles and connective tissues, reducing downtime between workouts and improving overall recovery rates

But your doctor just told you your testosterone is "fine," handed you a printout with a number in the reference range, and suggested you

These plans are: Monthly rolling membership: $149 per month

Furthermore, GLP-1Rs have been shown to be able to stimulate the depolarization-evoked release of other neurotransmitters, such as GABA and glutamate, as well as of serotonin and dopamine, in the cortex and hippocampus (Rebosio et al., 2018)

Hunter and Hlscher (2012) evaluated the capacity of the GLP-1 RAs liraglutide and lixisenatide to cross the BBB and elicit physiological effects within the brain [17]